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ABSTRACT.
Purpose: To illustrate Optical Coherence Tomography (OCT) images of active
and inactive retinoblastoma (Rb) tumours.
Methods: Current observational study included patients diagnosed with
retinoblastoma and retinoma who were presented at Amsterdam UMC and
Jules-Gonin Eye Hospital, between November 2010 and October 2017. Patients
aged between 0 and 4 years were imaged under general anaesthesia with handheld
OCT in supine position. Patients older than 4 years were imaged with the
conventional OCT (Heidelberg Engineering, Heidelberg Spectralis, Germany).
All patients included were divided into two groups: active and inactive tumours
(retinoma and regression patterns). Patients’ medical records and OCT images
were analysed during meetings via discussions by ophthalmologists and physicists.
Results: Twelve Dutch and 8 Swiss patients were divided into two groups: 2
patients with active tumour versus 18 patients with inactive tumour. Subse-
quently, inactive group could be divided in two groups, which consisted of 10
patients with retinoma and 8 patients with different regression pattern types. Of
all included patients, 15 were male (75%). Median age at diagnosis was
18.0 months (range 0.19–715.2 months). A total of 12 retinoblastoma (active
and inactive) and 8 retinoma foci were investigated by OCT. No distinction could
be made between active and inactive tumours using only OCT.
Conclusion: Optical coherence tomography alone cannot distinguish between
active and inactive Rbs. However, handheld OCT adds useful information to the
established imaging techniques in the monitoring and follow-up of retinoblas-
toma patients. With this study, we provide an overview of OCT images of active
and inactive Rbs.
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Introduction
Retinoblastoma (Rb) is the most com-
mon malignant paediatric ocular
tumour with an incidence of 1:17 000
(Moll 1996; Moll et al. 1997; Shields
et al. 2015). With the current standard
of care the survival rate of retinoblas-
toma cases is around 90–99% in devel-
oped countries (Jenkinson 2015).
Patients with retinoblastoma must be
frequently monitored under anaesthesia
before the age of five for early detection
of new or relapsed tumours, as well as
for the treatment and detection of side
effects, in order to reach these survival
rates (Yun et al. 2011). Retinoblastoma
can exhibit different regression patterns
after treatment. Tumour regression
patterns were originally defined as a
remnant lesion visible after external
beam radiotherapy (EBRT) (Dunphy
1964; Abramson et al. 1991; Singh
et al. 1993), but was later also applied
for tumour remnants after chemoreduc-
tion (Shields et al. 2009).
While retinoblastoma is a rapidly
growing malignancy, retinoma is a
benign retinal tumour characterized
by the absence of growth or shrinkage
over time (Dimaras et al. 2008; Shah
et al. 2011). The term ‘retinoma’ was
first introduced in the literature by
Gallie and colleagues (Gallie et al.
1982) based on the observations of 30
patients. It appears identical to
regressed tumours post-EBRT or
chemoreduction except that no
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treatment needs to be applied (Abou-
zeid et al. 2012).
Ocular oncologists use wide-angle
retinal photography and indirect oph-
thalmoscopy for retinoblastoma man-
agement (Haye et al. 1989). With these
tools it can be challenging to detect the
presence of active tumour tissue in
need of additional treatment. Due to
the limited real-time diagnostic options
ophthalmologists currently often rely
on monthly monitoring the patients at
risk under general anaesthesia. Conse-
quently, critical time might be lost in
case of tumour (re)growth. Early detec-
tion and characterization could avoid
(unnecessary) harmful treatments and
increase effectiveness of focal treatment
options that preserve better eye func-
tionality.
Optical coherence tomography
(OCT) is an established three-dimen-
sional imaging technique in ophthal-
mologic clinical practice with
demonstrated ability to improve diag-
nostic assessment and treatment deci-
sions in real time. Recently, it has been
expanded to a handheld ophthalmic
OCT configuration required for paedi-
atric retinoblastoma patients under
anaesthesia (Rootman et al. 2013; Lee
et al. 2016). A number of authors
suggested that adding OCT imaging
into the management decisions of
retinoblastoma could be essential
(Shields et al. 2005; Yousef et al.
2012; Rootman et al. 2013; Cao et al.
2014; Mallipatna et al. 2015; Sak-
tanasate et al. 2015; Berry et al. 2016;
Park et al. 2017; Shields & Shields
2017; Soliman et al. 2017; Gaillard
et al. 2018; Malik et al. 2018; Statho-
poulos et al. 2018). Handheld OCT has
been successfully utilized in diagnosis
(Rootman et al. 2013), detection of
clinically invisible smaller tumours
(Rootman et al. 2013; Saktanasate
et al. 2015; Berry et al. 2016), follow-
up of treatment results (Park
et al.2017; Gaillard et al. 2018), assess-
ment of optic nerve invasion (Yousef
et al. 2012; Mallipatna et al. 2015;
Fabian et al. 2017) and disease man-
agement decisions (Soliman et al. 2017)
for paediatric retinoblastoma patients
(under the age of four).
Currently, conventional OCT (Hei-
delberg Engineering, Heidelberg Spec-
tralis, Germany) is a widely used
imaging tool, especially in vitreoretinal
field. Only one commercial system with
handheld spectral domain OCT
(HHSD-OCT), (two generations of
Bioptigen Envusu C2200/Envisu
C2300, LeicaMicrosystemsMorrisville,
NS) operating at the central wavelength
of 860 nm, is available at only a few
specialized centres worldwide. There-
fore, the number of handheld OCT
studies in young retinoblastoma
patients is limited and more studies are
needed. For this clinical study, we
developed a novel handheld Swept
Source OCT system with 1050-nm cen-
tral wavelength for a deeper penetration
into the tumour.
We aimed to demonstrate an over-
view of OCT images of active and
inactive retinoblastoma tumours, dif-
ferent regression patterns and reti-
noma. The OCT images made with
the newly developed handheld imaging
system for retinoblastoma patients
(aged between 0 and 4 years, under
general anaesthesia), are shown
together with the conventional OCT




The present study is an observational
study including retinoblastoma and
retinoma patients from two centres
(Amsterdam UMC and the Jules-
Gonin Eye Hospital). All patients aged
between 0 and 4 years old were imaged
under anaesthesia with the novel hand-
held OCT. Patients older than or equal
to 4 years were imaged while seated
with the conventional OCT (Heidel-
berg Spectralis).
Inclusion and exclusion criteria
Dutch patients
Patients (n = 12) diagnosed with
retinoblastoma or retinoma and seen
between November 2014 and October
2017 during general anaesthesia ses-
sions were included. Exclusion criteria
were peripheral tumours, big tumours
(exceeding the focusing range and axial
field of view of the system due to their
extension towards the cornea), total
retinal detachment at the first clinical
presentation or due to lack of informed
consent from the guardians.
Swiss patients
All cases of retinoma (n = 8) present-
ing from November 2010 to December
2015 at the Jules-Gonin Eye Hospital
were retrospectively reviewed with
respect to fundus and OCT (Heidel-
berg Spectralis) imaging. Exclusion
criteria were: prior probatory treat-
ment; chemotherapy for retinoblas-
toma; OCT scans imaging of low
quality or failed to achieve due to
tumour size, retinal detachment or
anterior segment lesions.
Data collection and processing
The following clinical data were col-
lected via patient medical charts for all
the included patients: gender, age at
diagnosis, laterality at diagnosis (uni-,
bi- or trilateral), heredity, information
regarding the scanned eyes and scanned
tumours, number of tumours at diag-
nosis, tumour growth pattern, tumour
type (active tumour, slow growing
tumour, retinoma or regression types),
tumour location, staging of the tumour
(according to International Intraocular
Retinoblastoma Classification (IIRC)
and the American Joint Committee on
Cancer’s (AJCC) TNM-classification
system) (Linn Murphree 2005; Sobin
et al. 2010), therapy information and
follow-up data. All included tumours
were divided into active and inactive
lesions, with active ones subdivided into
tumours at diagnosis and active
tumours during therapy. Inactive
tumours were divided into: regression
pattern types and retinomas. Regres-
sion pattern types are defined according
to Wills Eye Institute classification:
type 0 – no tumor remnant/no retinal
scar visible, type I – completely calci-
fied tumour remnant (cottage cheese
scar), type II – fish flesh tumour
remnant (completely non-calcified
tumour remnant), type III – combina-
tion of calcified and fish flesh tumour
remnant and type IV – flat chorioreti-
nal scar (Shields et al. 2009). Retino-
mas were subdivided using the same
classification.
The OCT scans with the handheld
imaging system were analysed at
meetings and discussed by ophthal-
mologists and physicists using the
inclusion and exclusion criteria. We
additionally reviewed all the com-
bined clinical and imaging data: the
eligible OCT scans and retina images
(Retcam; Optos). Data and images are
presented in a descriptive form. No




Handheld OCT imaging procedure
Handheld OCT imaging (Fig. 1) was
performed during the routine clinical
sessions for Rb patients (under the
age of 4 years) in supine position
under inhalation anaesthesia. Work-
ing distance of the ophthalmic lens is
1 cm allowing for working with no
contact with patient’s cornea during
imaging. Artificial tears eye gel was
applied during imaging according to a
standard clinical practice. The laser
beam entered the eye through the
pupillary centre and the optimal
focusing was determined based on a
continuously acquired B-scan. To
achieve the best quality, the reference
arm was adjusted and the focusing
lens, followed by the polarization
compensator to offset the depolarizing
effect inside the patient’s eye. A
coarse en-face preview guided the
physician to the desired region of
interest and indicated if rescanning
was needed to improve the quality of
the images. The complete technical
description of our HHSD-OCT is
given in the angiography study (Nadi-
arnykh et al. 2019). The non-contact
imaging system provided lateral reso-
lution of 10–18 lm dependent on
focusing with the lateral field of view
up to 14 degrees, while axial reso-
lution was below 8 lm. For the
current study, we used only inten-
sity-based structural OCT imaging.
Results
Overall, 20 eyes from 12 Dutch and 8
Swiss patients were included in this
study. Baseline characteristics of the
study population are summarized in
Table 1. Of those, 15 patients were
male (75%). Median age at diagnosis
for the whole study population was
18.0 months (range 0.19–
715.2 months). Only 4 patients (20%)
had non-hereditary retinoblastoma
(unilateral cases without germline
mutation), while 10 patients (50%)
were affected with sporadic hereditary
Rb and 6 (30%) with a familial hered-
itary Rb. At imaging, locations of the
tumours were macula (n = 8, 40%),
macula–equator (n = 5; 25%), equator
(n = 3; 15%), ora serrata (n = 1; 5%),
and equator–ora (n = 3; 15%). Most of
the eyes were group B eyes (n = 16;
80%). Only two tumours were staged
as a group A (Linn Murphree 2005)
lesion. Both of them showed a flat
lesion on OCT imaging. Characteristics
of patients are listed in Table 2. Addi-
tional overview with a full description
per patient is provided in an online
supplementary material in
Appendix S1. OCT and funduscopy
images are demonstrated in figures
(Figs 2–4). Additional results regard-
ing fundus and OCT images are pre-
sented in an supporting information
(Appendix S2).
Active tumours
Two patients, one male and one
female, had an active tumour during
the scanning (Fig. 2 and Appendix S1:
patients HH1 and HH2). Both of them
were affected with hereditary bilateral
retinoblastoma and were scanned with
the novel handheld OCT at a young
age (2 and 3 months). These tumours
were located in the macula. One of
them is scanned at presentation (pa-
tient HH1), while the other was active
during the follow-up after therapy
(patient HH2).
Inactive tumours – regression patterns
Eighteen patients were included for the
inactive tumour group. We scanned
eight patients with regression patterns
as a remnant after therapy (Fig. 3 and
Appendix S1). Figure 3B and F both
show irregular surface with calcifica-
tions in the centre, characterized by
light scattering (observed as white
shadow under black lesions). Fig-
ure 3D shows a homogenous lesion
underneath a smooth surface, showing
a regression pattern type 3 in left eye of
a 1.5-year-old boy whose left eye was
treated with one cycle of intra-arterial
chemotherapy and laser therapy.
Inactive tumours – retinomas
Ten patients were scanned with reti-
noma, which showed no growth over
time (Fig. 4 and Appendix S2). The
majority of these (9 out of 10, 90%)
were scanned with Heidelberg OCT.
Eight patients (80%) with retinoma
had no prior treatments. Two remain-
ing patients (20%) were initially con-
sidered having retinoblastoma and
were subsequently diagnosed with reti-
noma when the lesion did not respond
to the therapy and showed no growth
over time (patients HH4 and SH1).
Fig. 1. Picture of the novel handheld OCT device during anaesthetic hours of Rb patients.
Table 1. Descriptive table of the whole study
population
Characteristic Total, n = 20










Scanned eye No (%)
Right eye 11 (55)
Left eye 9 (45)
Heredity No (%)
Non-hereditary, sporadic 4 (20)
Hereditary, sporadic 10 (50)
Hereditary, familial 6 (30)




Type tumour scanned No (%)
Active 2 (10)
Retinoma 10 (50)
Regression pattern types 8 (40)
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Figure 4B shows an OCT image of the
left eye of a 27-year-old male. Heidel-
berg OCT shows clear characteristics
of a flat type retinoma. Besides a
slightly irregular surface with a flat
centre, atrophy of the retina layers up
until retinal pigment epithelium are
observed. Figure 4D demonstrates an
OCT image of fish flesh retinoma, a
homogenous tumour mass, not
responding to any therapy. Three
blood vessels are observed on the upper
surface of the mass, characterized by
the shadowing underneath the vessels.
It must be noted that no signs of
calcification are seen in the OCT image
of this tumour remnant. After a longer
follow-up time, the lesion got smaller in
size, showing similar characteristics as
observations in regression type 2 (fish
flesh remnant).
Additional findings
OCT characteristics were further anal-
ysed in an attempt to distinguish active
and inactive tumours, but no distinct
features could be identified to differen-
tiate them (data not shown).
Most of the handheld OCT images
were easy to interpret and confirmed
generally the clinical signs seen in
fundus photography. A couple of
OCT images were ambiguous, mostly
due to a bigger tumour as observed in
Fig. 4F and H or because of the
location of the tumour.
Discussion
Optical coherence tomography is a
non-invasive imaging technique based
on interference of reflected laser light,
which is used to obtain cross-sectional
images of the posterior retina. The
conventional OCT (with a chinrest
Table 2. Characteristics of participants (per tumour type)
Type tumour n Gender Heredity Imaging Location Staging†
Active 2 M:1,
F:1
Sporadic: 1, Familial: 1 HHSD:2 Macula:2 pT1b pN0 cM0:2
Regression type 1* 1 M:1 Sporadic:1 HHSD:1 Macula:1 pT1c pN0 cM0:1
Regression type 2* 3 F:1,
M:2
Sporadic:1, Familial: 2 HHSD: 3 Macula: 3 pT1b pN0 cM0:2, pT1c
pN0 cM0:1
Regression type 3* 3 F:1,
M:2
Sporadic:2, Familial: 1 HHSD:3 Macula-equator:3 pT1b pN0c M0:2, pT1c
pN0 cM0:1
Regression type 4* 1 M:1 Sporadic:1 HHSD:1 Macula-equator:1 pT1a pN0 cM0:1
Retinoma type fish
flesh




Macula:2, Equator:1 pT1b pN0 cM0:3
Retinoma type flat 2 F:1,
M:1













1 M:1 Non-hereditary: 1 SH:1 Equator-ora:1 pT1b pN0 cM0:1
F = female, HHSD = Handheld Spectral Domain OCT, M = male, SH = Spectralis Heidelberg OCT.
Type tumour: Regression pattern types.
*Regression pattern types [Shields et al. 2009]: Type 0 = No tumour remnant; Type 1 = Calcified tumour remnant; Type 2 = Fish flesh; Type
3 = Mix; Type 4 = Flat.
†Staging was according to the Union for International Cancer Control/American Joint Committee on Cancer (UICC / AJCC) Tumour, Node,
Metastasis (TNM) categories and stages (7th Edition).
(A) (B)
(C) (D)
Fig. 2. Fundus picture and OCT scan of patients with active tumour. Active at diagnosis – Patient
HH1: (A) Fundus picture of the left eye at the diagnosis located in the centre of the macula. (B)
HHSD-OCT scans of the tumour in the left eye at the diagnosis showing an (endophytic and)
exophytic tumour with calcifications and a small retinal detachment. Active during therapy –
Patient HH2: (C) Fundus picture of the right eye 4 weeks after the diagnosis and one cycle of
systemic Carboplatin. (D) HHSD-OCT image of the right eye demonstrating a vital tumour
2 months after diagnosis (and two cycles of systemic Carboplatin).
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and no general anaesthesia) in
retinoblastoma patients was first
described in literature by Shields and
associates in 2004 (Shields et al. 2004).
They investigated the role of conven-
tional OCT in fundus tumours in a
retrospective single-centre case series of
44 retinoblastoma patients younger
than 18 years. Authors compared their
findings with OCT to those of clinical
examination and ultrasonography.
They showed that in comparison with
clinical examination, OCT is more
sensitive in the detection of macular
pathology, surface wrinkling macu-
lopathy, macular oedema, subfoveal
fluid and retinal thinning. Further-
more, in comparison with ultrasonog-
raphy, OCT tends to be more sensitive
in detection of surface wrinkling mac-
ulopathy, non-cystoid macular oedema
and subfoveal fluid.
At present, OCT is a widely used
imaging modality in ophthalmology,
but its use cannot be implemented
easily for young infants examined in
supine position under anaesthesia,
without the adapted handheld tech-
nique, first introduced by Scott et al.
(2009).
In the present study, we imple-
mented a new handheld OCT imaging
system together with the conventional
OCT imaging for retinoblastoma and
retinoma patients. We aimed to docu-
ment OCT imaging findings in active
and inactive retinoblastoma as well as
in retinoma. To the best of our knowl-
edge, this is the first comprehensive
study in literature giving an overview
for retinoblastoma patients systemati-
cally demonstrating different regression
patterns as well as retinomas based on
images made with handheld and con-
ventional OCT.
Recently, Malik and associates
described the importance of handheld
OCT in an observational case report
(Malik et al. 2018). A 15-month-old
girl was diagnosed with bilateral
retinoblastoma after presenting with
leukocoria in the left eye. Macular
tumour in the left eye was unresponsive
to chemotherapy, but reacted well to
plaque radiotherapy, which could be
confirmed by imaging with the hand-
held OCT. The authors underline the
critical role of handheld OCT in the
assessment of treatment results in
retinoblastoma tumour, especially in
macular tumours unresponsive to
chemotherapy.
A retrospective study reviewing
medical records of 557 retinoblastoma
patients for evaluation of the change in
regression patterns following chemo-
reduction (Palamar et al. 2011) showed
that most of the changes appeared as
non-calcified fish flesh remnant or
evolving into a calcified remnant. Most
of the changes occurs in the first
6 months after the last cycle of
chemoreduction. It is therefore impor-





Fig. 3. Fundus picture and OCT scan of patients with inactive tumours (regression patterns).
Regression pattern type I – Patient HH11: (A) Fundus picture and (B) HHSD-OCT scans of the
right eye. After therapy, a fully calcified remnant was observed. Regression pattern type II –
Fundus picture and HHSD-OCT scan. (C,D) Left eye in patient HH5; Ten months after the
detection and therapy. Blue arrow pointing to the lesion in the left eye in patient HH5 occurring
after one cycle of intra-arterial chemotherapy and not reacting to laser therapy. Regression pattern
type III – (E,F) Fundus picture and HHSD-OCT of Patient HH8 Mass in the left eye. Regression
of the lesion in reaction to Ruthenium plaque, after systemic chemotherapy and laser.
Combination of calcified and fish flesh remnant is seen. Regression pattern IV – (G,H) Fundus
picture and HHSD-OCT of left eye in patient HH10; flat lesion (atrophic) after treatment with
chemotherapy. Blue arrow pointing to the lesion in fundus picture, lesion stays stable over time.
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regression patterns after chemother-
apy, especially regression types 2 and
3, because of their relapsing potential
over time (Palamar et al. 2011). These
changes can also be seen in tumours
without any additional treatments after
chemoreduction. Others have also
reported evolution of retinoma over a
period of 20 years (Lam et al. 2005).
In 2009, Shields and associates ret-
rospectively evaluated regression pat-
terns following chemoreduction and
adjuvant therapy in medical records
of 557 patients (Shields et al. 2009). In
that study they reported a correlation
between regression types and tumour
thickness. Tumours with a thickness of
less than 3 mm evolved more often in a
regression pattern type 4; whereas
those with 3–8 mm regressed to type
3 or 4 and those with a thickness of
more than 8 mm developed into a
regression pattern type 1 or 3. Results
also showed that macular location,
older age, foveolar proximity, lack of
consolidation and larger tumour base
were the factors predictive of regression
pattern type 3. For regression pattern
type 4, those factors were familial
hereditary pattern, greater foveolar
distance, tumour consolidation and
smaller tumour base. Most recently,
Chawla and colleagues reported similar
results (Chawla et al. 2016).
The real benefits of OCT imaging are
most useful during follow-up sessions
where treatment effects, regression pat-
terns and possible tumour recurrences
have to be visualized and diagnosed.
However, we were able to identify a
number of important limitations for the
OCT imaging of Rb. The far peripheral
lesions are not accessible due to an
unsatisfactory image quality. Further-
more, only the top part of the volume is
accessible in large masses and no details
can be obtained from regions beneath
calcification due to a rapid attenuation
of signal.MRI and ultrasonography are
used for the management of bigger
tumours as a part of standard of care
(Dimaras et al. 2015). Another limita-
tion to this optical technique is that it
depends on the transparency of the
media (Dimaras & Corson 2019).
Shields and associates (Shields et al.
2005) described in a previous study that
internal reflectivity of calcified tumours
may be higher showing a back scatter-
ing response and a much denser sha-
dow behind the layers of the tumour.
We observed these features in most of
the tumours containing calcifications.
Although, the primary aim of the
current study was to demonstrate OCT
images of active and inactive Rb
tumours, we additionally tried to dis-
tinguish between them solely with OCT
imaging. We hypothesized that the
active Rb tumours will be characterized
with typical OCT imaging-specific fea-
tures (such as vascularization and
internal reflectivity) that will help dis-








Fig. 4. Fundus picture and OCT scan of patients with inactive tumours (retinomas). Flat retinoma
– Patient SH2: (A,B) Tumour of the left eye; Irregular surface with flat central remnant is seen in
OCT (Heidelberg). Fish flesh retinoma – Fundus picture and Heidelberg OCT of Patient SH1: (C,
D) At diagnosis and after chemotherapy and partial laser treatment, the tumour did not change; a
retinoma like mass was still observed in the right eye. After a longer follow-up over time, it got
smaller in size similar to observations as in regression type 2. Calcified retinoma – (E,F) Fundus
picture and Heidelberg OCT of Patient SH7. Endophytic tumour of the right eye, located
inferiorly to the optic nerve. The lesion was discovered during a routine examination for eye
glasses prescription in a 61-year-old woman, without any treatment and appeared stable during
follow up. Mixed retinoma – Fundus picture and Heidelberg OCT of Patient SH9: (G,H)
Endophytic tumour with fish flesh tissue and calcification detected in the right eye of a 2-year-old
girl whose left eye presented a retinoblastoma group D. No change was noticed during the follow-
up. This eye received no treatment. The (Heidelberg) OCT shows a homogenous mass with
smooth surface and rare calcifications.
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tumours. Unfortunately, we were not
able to identify these features with the
OCT systems used for this study. Thus,
based on the images obtained in the
present study, OCT alone is not able to
objectively differentiate between active
and inactive retinoblastoma tumours.
Hence, a clinician’s judgement and
follow-up over time are still required.
In our case series with calcified
regression pattern types (types I and
III, Fig. 3B and F), OCT demonstrated
black lesions with strong light scatter-
ing. Although this visual feature is
typical for calcification, it is not unique
or exclusive to calcification. Similar
black lesions (opaque regions with
shadow effect) are also observed in
blood vessels. We distinguished calcifi-
cation from blood vessels using en-face
OCT projections and fundus images,
where we almost certainly excluded the
possibility of blood vessels in specific
areas. To visualize blood vessels with a
better sensitivity, in our concurrent
work we implemented an angiographic
capability in our handheld OCT for
mapping of blood vasculature in the
vicinity of Rb tumours and retinomas
(Nadiarnykh et al. 2019).
The results of current literature are
promising. However, the number of
cases studied remains modest in com-
bination with a high heterogeneity in
patients. Moreover, there is a high
variability in morphology of affected
retinal layers with variable features
between different patients. Similar to
the findings of Soliman et al. (2017) we
observed the value of OCT imaging in
precise localization of tumour masses
and regression patterns in the fovea
region. In some cases, this information
might be useful for the treatment and
follow-up decisions with respect to the
potential for visual functionality.
Conclusion
Handheld swept-source optical coher-
ence tomography is a relatively new
technique to obtain images of the
retina in retinoblastoma patients, espe-
cially in paediatric patients (aged 0–4)
examined under general anaesthesia.
Based on our results we suggest that
OCT alone cannot make a reliable
distinction between active and inactive
retinoblastoma tumours. However,
handheld OCT adds useful information
to the established imaging techniques
in the monitoring and follow-up of
retinoblastoma patients, especially in
the visualizing and the evaluation of
different regression patterns.
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